Method for the synthesis of compounds of formula I and their uses thereof
AssigneeTransTech Pharma, Inc.
InventorsAdnan M. M. Mjalli, Ramesh Gopalaswamy, Kwasi A. Avor, Christopher L. Wysong, Patron Andrew
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransTech Pharma, Inc.
InventorsAdnan M. M. Mjalli, Ramesh Gopalaswamy, Kwasi A. Avor, Christopher L. Wysong, Patron Andrew
Estimating the term…
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, β-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis.
A compound comprising at least one moiety of the formula
Dependencies are inferred from the claim text.